These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29276154)

  • 1. Modeling the Pathogenesis of Charcot-Marie-Tooth Disease Type 1A Using Patient-Specific iPSCs.
    Shi L; Huang L; He R; Huang W; Wang H; Lai X; Zou Z; Sun J; Ke Q; Zheng M; Lu X; Pei Z; Su H; Xiang AP; Li W; Yao X
    Stem Cell Reports; 2018 Jan; 10(1):120-133. PubMed ID: 29276154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
    Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
    Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells.
    Prior R; Silva A; Vangansewinkel T; Idkowiak J; Tharkeshwar AK; Hellings TP; Michailidou I; Vreijling J; Loos M; Koopmans B; Vlek N; Agaser C; Kuipers TB; Michiels C; Rossaert E; Verschoren S; Vermeire W; de Laat V; Dehairs J; Eggermont K; van den Biggelaar D; Bademosi AT; Meunier FA; vandeVen M; Van Damme P; Mei H; Swinnen JV; Lambrichts I; Baas F; Fluiter K; Wolfs E; Van Den Bosch L
    Brain; 2024 Sep; 147(9):3113-3130. PubMed ID: 38743588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of one induced pluripotent stem cell line JUCGRMi004-A from a Charcot-Marie-Tooth disease type 1A (CMT1A) patient with PMP22 duplication.
    Liu X; Ishikawa KI; Hattori N; Akamatsu W
    Stem Cell Res; 2024 Jun; 77():103401. PubMed ID: 38537501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
    Hanemann CO; Müller HW
    Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of PMP22 ameliorates myelin defects in iPSC-derived human organoid cultures of CMT1A.
    Van Lent J; Vendredy L; Adriaenssens E; Da Silva Authier T; Asselbergh B; Kaji M; Weckhuysen S; Van Den Bosch L; Baets J; Timmerman V
    Brain; 2023 Jul; 146(7):2885-2896. PubMed ID: 36511878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of Human Tonsil-Derived Mesenchymal Stem Cells into Schwann-Like Cells Improves Neuromuscular Function in a Mouse Model of Charcot-Marie-Tooth Disease Type 1A.
    Park S; Jung N; Myung S; Choi Y; Chung KW; Choi BO; Jung SC
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30110925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S; Scherer SS; Nave KA; Suter U
    J Neurosci Res; 2002 Feb; 67(4):443-9. PubMed ID: 11835311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
    Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFβ4 alleviates the phenotype of Charcot-Marie-Tooth disease type 1A.
    Jeon H; Jang SY; Kwak G; Yi YW; You MH; Park NY; Jo JH; Yang JW; Jang HJ; Jeong SY; Moon SK; Doo HM; Nahm M; Kim D; Chang JW; Choi BO; Hong YB
    Brain; 2023 Sep; 146(9):3608-3615. PubMed ID: 37143322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PMP22 expression in dermal nerve myelin from patients with CMT1A.
    Katona I; Wu X; Feely SM; Sottile S; Siskind CE; Miller LJ; Shy ME; Li J
    Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
    Lee JS; Lee JY; Song DW; Bae HS; Doo HM; Yu HS; Lee KJ; Kim HK; Hwang H; Kwak G; Kim D; Kim S; Hong YB; Lee JM; Choi BO
    Nucleic Acids Res; 2020 Jan; 48(1):130-140. PubMed ID: 31713617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of peripheral myelin protein 22 in onion bulbs and Schwann cells of biopsied nerves from patients with Charcot-Marie-Tooth disease type 1A.
    Nishimura T; Yoshikawa H; Fujimura H; Sakoda S; Yanagihara T
    Acta Neuropathol; 1996 Nov; 92(5):454-60. PubMed ID: 8922056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy.
    Nobbio L; Sturla L; Fiorese F; Usai C; Basile G; Moreschi I; Benvenuto F; Zocchi E; De Flora A; Schenone A; Bruzzone S
    J Biol Chem; 2009 Aug; 284(34):23146-58. PubMed ID: 19546221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
    Sociali G; Visigalli D; Prukop T; Cervellini I; Mannino E; Venturi C; Bruzzone S; Sereda MW; Schenone A
    Neurobiol Dis; 2016 Nov; 95():145-57. PubMed ID: 27431093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV-mediated editing of PMP22 rescues Charcot-Marie-Tooth disease type 1A features in patient-derived iPS Schwann cells.
    Yoshioka Y; Taniguchi JB; Homma H; Tamura T; Fujita K; Inotsume M; Tagawa K; Misawa K; Matsumoto N; Nakagawa M; Inoue H; Tanaka H; Okazawa H
    Commun Med (Lond); 2023 Nov; 3(1):170. PubMed ID: 38017287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages.
    Hanemann CO; Gabreëls-Fasten AA; Müller HW; Stoll G
    Brain; 1996 Oct; 119 ( Pt 5)():1461-9. PubMed ID: 8931571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients.
    Lee S; Bazick H; Chittoor-Vinod V; Al Salihi MO; Xia G; Notterpek L
    Am J Pathol; 2018 Mar; 188(3):728-738. PubMed ID: 29246495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.